Acuitas Investments, LLC Sera Prognostics, Inc. Transaction History

Acuitas Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$5.05 - $10.0 $278,830 - $552,140	-55,214 Reduced 45.53%	66,044 $601,000
Q4 2023 Feb 02, 2024	SELL	$1.65 - $6.85 $85,696 - $355,768	-51,937 Reduced 29.99%	121,258 $725,000
Q3 2023 Oct 27, 2023	SELL	$1.55 - $3.34 $10 - $23	-7 Reduced -0.0%	173,195 $322,000
Q2 2023 Aug 07, 2023	BUY	$3.0 - $3.98 $519,606 - $689,343	173,202 New	173,202 $569,000

20.3M

120K

Ticker SERA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 29,596,900
Market Cap $201M
Description
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...

Get notified when there are updates to the investment portfolio of Acuitas Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Acuitas Investments, LLC with notifications on news.